Introduction: Aneurysmal subarachnoid hemorrhage (aSAH) represents 3% of all strokes in
the US. When the patient survives it can lead to permanent incapacity especially if the …

✓ Cerebral vasospasm and delayed cerebral ischemia remain common complications of
aneurysmal subarachnoid hemorrhage (SAH), and yet therapies for cerebral vasospasm are …

OBJECTIVE: Cerebral vasospasm is a major source of morbidity and mortality following
aneurysmal subarachnoid hemorrhage (SAH). A variety of therapies have been utilized to …

Introduction: The vast amount of literature on the pharmaceutical treatment of cerebral
vasospasm after aneurysmal subarachnoid hemorrhage remains daunting. Optimal …

Cerebral vasospasm is a major source of morbidity and mortality in patients with aneurysmal
subarachnoid hemorrhage (aSAH). Evidence suggests a multifactorial etiology and this …

Aneurysmal subarachnoid hemorrhage (aSAH) continues to be associated with significant
morbidity and mortality despite advances in care and aneurysm treatment strategies …

Aneurysmal subarachnoid hemorrhage (aSAH) affects approximately 6–9 individuals per
100,000 population [1]. Early repair of ruptured aneurysm by endovascular coiling or …

The clinical management of aneurysmal subarachnoid hemorrhage (SAH)-associated
vasospasm remains a challenge in neurosurgical practice, with its prevention and treatment …

The occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH)
is a significant event resulting in decreased cerebral blood flow and oxygen delivery …

Objectives: Cerebral vasospasm is one of the leading causes of morbi-mortality following
aneurysmal subarachnoid hemorrhage. The aim of this article is to discuss the current status …